🇺🇸 FDA
Patent

US 7112317

Combined methods and compositions for tumor vasculature targeting and tumor treatment

granted A61KA61K2039/505A61K2123/00

Quick answer

US patent 7112317 (Combined methods and compositions for tumor vasculature targeting and tumor treatment) held by The Board of Regents of the University of Texas System expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K2123/00, A61K38/00, A61K47/6817